Impact of Empiric Nesiritide or Milrinone Infusion on Early Postoperative Recovery Following Fontan Surgery: a Randomized, Double-blind, Placebo-controlled Clinical Trial.
Phase of Trial: Phase II
Latest Information Update: 27 Jun 2018
At a glance
- Drugs Nesiritide (Primary) ; Milrinone
- Indications Congenital heart defects; Postoperative complications
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 18 Nov 2013 Primary endpoint 'Event-free-survival-rate' has not been met.
- 18 Nov 2013 Results presented at the 86th Annual Scientific Sessions of the American Heart Association.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History